Details
Description
The goal of this request was to examine the number of new users of oral bisphosphonates (including oral formulations of generic alendronate sodium, etidronate disodium, ibandronate sodium, risedronate sodium, or tiludronate disodium) with continuous long-term treatment in the Mini-Sentinel Distributed Database (MSDD). Data from January 1, 2000 to December 31, 2012 from 18 Data Partners contributing to the MSDD were included in this report. This request was distributed to Data Partners on August 9, 2013.